NCT01409915: A trial that was reported late by University of Colorado, Denver
This trial has reported, although it was 78 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01409915 |
|---|---|
| Title | Pilot Phase 2 Trial of the Safety & Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor (Leukine®) in the Treatment of Alzheimer's Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 31, 2011 |
| Completion date | Dec. 9, 2019 |
| Required reporting date | Dec. 8, 2020, midnight |
| Actual reporting date | Feb. 25, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 78 |